Skip Nav Destination
Issues
Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox.
Diabetes October 1999, Vol.48, 1899-1906. doi:https://doi.org/10.2337/diabetes.48.10.1899
Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation?
W Bennet; B Sundberg; C G Groth; M D Brendel; D Brandhorst; H Brandhorst; R G Bretzel; G Elgue; R Larsson; B Nilsson; O Korsgren
Diabetes October 1999, Vol.48, 1907-1914. doi:https://doi.org/10.2337/diabetes.48.10.1907
No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans.
Diabetes October 1999, Vol.48, 1915-1921. doi:https://doi.org/10.2337/diabetes.48.10.1915
Calorie restriction increases insulin-stimulated glucose transport in skeletal muscle from IRS-1 knockout mice.
Diabetes October 1999, Vol.48, 1930-1936. doi:https://doi.org/10.2337/diabetes.48.10.1930
T-cell production of an inducible interleukin-10 transgene provides limited protection from autoimmune diabetes.
Diabetes October 1999, Vol.48, 1948-1953. doi:https://doi.org/10.2337/diabetes.48.10.1948
Mechanisms of glucose hypersensitivity in beta-cells from normoglycemic, partially pancreatectomized mice.
F Martín; E Andreu; J M Rovira; J A Pertusa; M Raurell; C Ripoll; J V Sanchez-Andrés; E Montanya; B Soria
Diabetes October 1999, Vol.48, 1954-1961. doi:https://doi.org/10.2337/diabetes.48.10.1954
Mechanisms of coordination of Ca2+ signals in pancreatic islet cells.
Diabetes October 1999, Vol.48, 1971-1978. doi:https://doi.org/10.2337/diabetes.48.10.1971
Altered cAMP and Ca2+ signaling in mouse pancreatic islets with glucagon-like peptide-1 receptor null phenotype.
D Flamez; P Gilon; K Moens; A Van Breusegem; D Delmeire; L A Scrocchi; J C Henquin; D J Drucker; F Schuit
Diabetes October 1999, Vol.48, 1979-1986. doi:https://doi.org/10.2337/diabetes.48.10.1979
Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice.
L Scheja; L Makowski; K T Uysal; S M Wiesbrock; D R Shimshek; D S Meyers; M Morgan; R A Parker; G S Hotamisligil
Diabetes October 1999, Vol.48, 1987-1994. doi:https://doi.org/10.2337/diabetes.48.10.1987
In vivo prevention of hyperglycemia also prevents glucotoxic effects on PDX-1 and insulin gene expression.
Diabetes October 1999, Vol.48, 1995-2000. doi:https://doi.org/10.2337/diabetes.48.10.1995
Unresponsiveness to glibenclamide during chronic treatment induced by reduction of ATP-sensitive K+ channel activity.
J Kawaki; K Nagashima; J Tanaka; T Miki; M Miyazaki; T Gonoi; N Mitsuhashi; N Nakajima; T Iwanaga; H Yano; S Seino
Diabetes October 1999, Vol.48, 2001-2006. doi:https://doi.org/10.2337/diabetes.48.10.2001
Palmitate and oleate induce the immediate-early response genes c-fos and nur-77 in the pancreatic beta-cell line INS-1.
Diabetes October 1999, Vol.48, 2007-2014. doi:https://doi.org/10.2337/diabetes.48.10.2007
Evidence for a functional role of the cholecystokinin-B/gastrin receptor in the human fetal and adult pancreas.
C Saillan-Barreau; M Dufresne; P Clerc; D Sanchez; H Corominola; C Moriscot; O Guy-Crotte; C Escrieut; N Vaysse; R Gomis; N Tarasova; D Fourmy
Diabetes October 1999, Vol.48, 2015-2021. doi:https://doi.org/10.2337/diabetes.48.10.2015
Metabolic impact of glucokinase overexpression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia.
Diabetes October 1999, Vol.48, 2022-2027. doi:https://doi.org/10.2337/diabetes.48.10.2022
Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action.
K Ebihara; Y Ogawa; G Katsuura; Y Numata; H Masuzaki; N Satoh; M Tamaki; T Yoshioka; M Hayase; N Matsuoka; M Aizawa-Abe; Y Yoshimasa; K Nakao
Diabetes October 1999, Vol.48, 2028-2033. doi:https://doi.org/10.2337/diabetes.48.10.2028
Rapid increase in circulating leptin in ventromedial hypothalamus-lesioned rats: role of hyperinsulinemia and implication for upregulation mechanism.
A Suga; T Hirano; H Kageyama; M Kashiba; J Oka; T Osaka; Y Namba; M Tsuji; M Miura; M Adachi; S Inoue
Diabetes October 1999, Vol.48, 2034-2038. doi:https://doi.org/10.2337/diabetes.48.10.2034
Insulin resistance during puberty: results from clamp studies in 357 children.
Diabetes October 1999, Vol.48, 2039-2044. doi:https://doi.org/10.2337/diabetes.48.10.2039
Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy.
Diabetes October 1999, Vol.48, 2045-2051. doi:https://doi.org/10.2337/diabetes.48.10.2045
Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo.
Diabetes October 1999, Vol.48, 2052-2058. doi:https://doi.org/10.2337/diabetes.48.10.2052
Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation.
Diabetes October 1999, Vol.48, 2066-2073. doi:https://doi.org/10.2337/diabetes.48.10.2066
Low phagocytic activity of resident peritoneal macrophages in diabetic mice: relevance to the formation of advanced glycation end products.
Diabetes October 1999, Vol.48, 2074-2082. doi:https://doi.org/10.2337/diabetes.48.10.2074
Regulation of the laminin C1 promoter in cultured mesangial cells.
Diabetes October 1999, Vol.48, 2083-2089. doi:https://doi.org/10.2337/diabetes.48.10.2083
A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats.
J Nakamura; K Kato; Y Hamada; M Nakayama; S Chaya; E Nakashima; K Naruse; Y Kasuya; R Mizubayashi; K Miwa; Y Yasuda; H Kamiya; K Ienaga; F Sakakibara; N Koh; N Hotta
Diabetes October 1999, Vol.48, 2090-2095. doi:https://doi.org/10.2337/diabetes.48.10.2090
Tumor necrosis factor-alpha-238 and -308 polymorphisms do not associated with traits related to obesity and insulin resistance.
Diabetes October 1999, Vol.48, 2096-2098. doi:https://doi.org/10.2337/diabetes.48.10.2096
Hepatocyte nuclear factor-4gamma: cDNA sequence, gene organization, and mutation screening in early-onset autosomal-dominant type 2 diabetes.
N Plengvidhya; A Antonellis; L T Wogan; A Poleev; M Borgschulze; J H Warram; G U Ryffel; A S Krolewski; A Doria
Diabetes October 1999, Vol.48, 2099-2102. doi:https://doi.org/10.2337/diabetes.48.10.2099